When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
KALA - FDA rejects Kala Pharma's KPI-121 for dry eye
Kala Pharmaceuticals Inc.
Kala Pharmaceuticals (NASDAQ:KALA) may encounter some volatility after receiving a CRL from the FDA regarding its marketing application for dry eye disease candidate KPI-121. The agency stated that another clinical will be needed.
More news on: Kala Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move,